Teresa Amaral

Vertaling van ctDNA naar de klinische melanoompraktijk: internationale expertsurvey

Expanding access to cancer immunotherapy: A systematic review of low-dose PD-(L)1 inhibitor strategies.

Real-world adjuvant bij stadium III BRAF-gemuteerd melanoom: vergelijking

European consensus-based interdisciplinary guideline for melanoma. Part 1: Diagnostics - Update 2024.

European consensus-based interdisciplinary guideline for melanoma. Part 2: Behandeling - Update 2024.

Melanoomdiagnostiek: Europese consensus 2022 update deel 1

Melanoombehandeling: Europese consensus 2022 update deel 2